Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026

Go back to Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.19 -0.03 (1.35%)
Previous Close $2.22    52 Week High $1.11 
Open $2.21    52 Week Low $0.41 
Day High $2.27    P/E N/A 
Day Low $2.18    EPS $-0.29 
Volume 268,584